| scholarly article | Q13442814 |
| P2093 | author name string | George G Nomikos | |
| George Panagis | |||
| Ada Mitsacos | |||
| Panagiotis Giompres | |||
| Maria Mavrikaki | |||
| Eleni Fanarioti | |||
| P2860 | cites work | Dopamine release in the basal ganglia | Q22251247 |
| Cloning and expression of human and rat D1 dopamine receptors | Q24306738 | ||
| Cannabinoid pharmacology: the first 66 years | Q24670395 | ||
| Presynaptic dopamine modulation by stimulant self-administration | Q26823507 | ||
| The effects of cannabinoids on the brain | Q28137626 | ||
| Distinct functions of the two isoforms of dopamine D2 receptors | Q28138415 | ||
| Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 | ||
| Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor | Q28145385 | ||
| The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study | Q28207211 | ||
| Human dopamine D1 receptor encoded by an intronless gene on chromosome 5 | Q28258672 | ||
| Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons | Q28272251 | ||
| Cloning and expression of a rat D2 dopamine receptor cDNA | Q28567326 | ||
| Cloning and functional characterization of a cocaine-sensitive dopamine transporter | Q28577393 | ||
| Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum | Q28585149 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain | Q30047898 | ||
| Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data | Q30807024 | ||
| Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens | Q31877443 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? | Q33211909 | ||
| Functional changes of the basal ganglia circuitry in Parkinson's disease. | Q33924857 | ||
| CB2: a cannabinoid receptor with an identity crisis | Q34098185 | ||
| Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. | Q34102344 | ||
| Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling | Q34166000 | ||
| Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output | Q34248777 | ||
| The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons | Q34370362 | ||
| Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra | Q34421920 | ||
| Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum | Q34432376 | ||
| Is there a common molecular pathway for addiction? | Q34463226 | ||
| Light microscopic autoradiographic localisation in rat brain of the binding sites for the GABAA receptor antagonist [3H]SR 95531: comparison with the [3H]GABAA receptor distribution | Q48098553 | ||
| Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange | Q48198217 | ||
| Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment | Q48209713 | ||
| Chronic WIN55,212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat. | Q48335396 | ||
| WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release | Q48386767 | ||
| Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats | Q48457844 | ||
| Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors | Q48534524 | ||
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. | Q48658239 | ||
| Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions | Q48696308 | ||
| Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. | Q50913375 | ||
| The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress. | Q51083991 | ||
| Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. | Q51502955 | ||
| GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. | Q52023779 | ||
| Alternative splicing directs the expression of two D2 dopamine receptor isoforms. | Q55058608 | ||
| Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells | Q61479730 | ||
| Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice | Q69852000 | ||
| Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study | Q72656516 | ||
| Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain | Q73101567 | ||
| Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain | Q73229635 | ||
| Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment | Q73500317 | ||
| Activational role of cannabinoids on movement | Q73575705 | ||
| Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. | Q43805334 | ||
| Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors | Q43854201 | ||
| Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. | Q43873792 | ||
| Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids | Q44051647 | ||
| Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse | Q44084440 | ||
| Behavioral sensitization to amphetamine follows chronic administration of the CB1 agonist WIN 55,212-2 in Lewis rats | Q44126671 | ||
| Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice | Q44138847 | ||
| Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study | Q44182591 | ||
| Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 | ||
| Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia | Q44451116 | ||
| Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat. | Q44555339 | ||
| Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia | Q44865127 | ||
| Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. | Q44885114 | ||
| Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration | Q44920764 | ||
| Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex--involvement of Na(+)/K(+)-ATPase | Q44946148 | ||
| Amphetamine effects on dopamine levels and behavior following cannabinoid exposure during adolescence | Q45014980 | ||
| Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta | Q45053894 | ||
| The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently | Q45174910 | ||
| Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity | Q46323561 | ||
| Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. | Q46384445 | ||
| Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum | Q46406572 | ||
| Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain | Q46425083 | ||
| Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity | Q46442166 | ||
| Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine | Q46673452 | ||
| Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant | Q46866063 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders | Q35586641 | ||
| Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids | Q35672460 | ||
| The mechanism of amphetamine-induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro. | Q35756737 | ||
| Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. | Q36119168 | ||
| Endocannabinoid signaling system and brain reward: emphasis on dopamine | Q36152336 | ||
| Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems. | Q36234294 | ||
| Effects of cannabinoids on neurotransmission. | Q36441200 | ||
| The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction | Q36478275 | ||
| Prominence of the dopamine D2 short isoform in dopaminergic pathways | Q36507451 | ||
| The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing | Q36630516 | ||
| The endocannabinoid system in brain reward processes | Q36741861 | ||
| Endocannabinoids and synaptic function in the CNS. | Q36778581 | ||
| Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). | Q36927168 | ||
| D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling | Q37130639 | ||
| Habits, rituals, and the evaluative brain | Q37193050 | ||
| Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. | Q37734568 | ||
| A brain on cannabinoids: the role of dopamine release in reward seeking | Q38036236 | ||
| Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors | Q38207415 | ||
| Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 | ||
| Modulation of neurotransmitter release by presynaptic autoreceptors | Q38357259 | ||
| Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors | Q40055727 | ||
| Dendritic release of dopamine in the substantia nigra | Q40123417 | ||
| Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter | Q40623607 | ||
| Recent advances in the molecular biology of dopamine receptors | Q40890829 | ||
| Electrophysiological pharmacology of the autoreceptor-mediated responses of dopaminergic cells to antiparkinsonian drugs. | Q41560128 | ||
| Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice. | Q41879862 | ||
| Ventral tegmental ionotropic glutamate receptor stimulation of nucleus accumbens tonic dopamine efflux blunts hindbrain-evoked phasic neurotransmission: implications for dopamine dysregulation disorders. | Q42443464 | ||
| Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats | Q42469510 | ||
| Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior | Q42474126 | ||
| Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains | Q42490661 | ||
| Ectopic expression of TrKA in the adult rat basal ganglia induces both nerve growth factor-dependent and -independent neuronal responses | Q42503430 | ||
| Localization of cannabinoid receptor mRNA in rat brain | Q42510202 | ||
| Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. | Q42513159 | ||
| Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. | Q42520647 | ||
| Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons | Q42523185 | ||
| Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study | Q42617028 | ||
| Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats | Q42645153 | ||
| Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain | Q43235028 | ||
| Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited. | Q43355908 | ||
| The psychoactive ingredient of marijuana induces behavioural sensitization. | Q43750238 | ||
| The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. | Q43791910 | ||
| P433 | issue | 6 | |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P577 | publication date | 2014-12-07 | |
| P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
| P1476 | title | Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. | |
| P478 | volume | 18 |
Search more.